Health Care Equipment

SISRAM MED

Today’s Key News Recap

DPSK

NVDA

NOVAQ

NOVA

01696

NVMI

AAPL

603020

GOOG

GOOGL

AMZN

OpenAI

DXYZ

NVDL

07788

07388

NVDY

NVDD

NVDX

NVDQ

1202 | Dolphin Research Key Focus: 🐬 Macro/Industry 1. DeepSeek simultaneously launched two official versions of AI models, DeepSeek-V3.2 and DeepSeek-V3.2-Speciale. The former's inference capability is close to GPT-5, with tool invocation reaching the top level of open-source models; the latter won four international competition gold medals, specializing in complex tasks. The models introduce the DSA sparse attention mechanism, significantly reducing inference costs. The dual-model strategy precisely covers different needs, and technological breakthroughs narrow the gap between open-source and closed-source models...

DeepSeek

NVIDIA

SUNNOVA ENERGY INTERNATIONAL INC

Sunnova Energy

Nova

Apple

Apple Group

Alphabet - C

Alphabet

Amazon

Destiny Tech100

GraniteShares 2x Long NVDA Daily ETF

XL2CSOPNVDA

XI2CSOPNVDA

YieldMax NVDA Option Income Strategy ETF

Direxion Daily NVDA Bear 1X ETF

T-Rex 2X Long NVIDIA Daily Target ETF

T-Rex 2X Inverse NVIDIA Daily Target ETF

Global Tech Blitz: Nvidia Invests in Synopsys, Apple AI Shakeup, Alibaba Updates AI Model | Today's Important News Recap

Intel

Conference Minutes

00981

SFTBY

9984

SOBKY

MBLY

ASIC

LAKE

SOXS

SOXL

SOXX

CP00062

INTC

HSMD

688981

CCGWW

04335

The following are the minutes of the Q3 2025 earnings call for $Intel(INTC.US) compiled by Dolphin Research. For an interpretation of the earnings report, please refer to &#34;Intel: Stopping Losses and Recovering! Can the 'American SMIC' Poach TSMC?&#34; 1. Core Financial Data of Intel's Earnings Report Q3 Financial Data: Revenue: $13.7 billion, exceeding the upper limit of the expected range, with a quarter-on-quarter growth of 6%. Gross Margin: (Non-GAAP) Gross margin was 40%, 4 percentage points higher than the performance guidance. This performance was attributed to revenue growth, improved product mix, and reduced inventory write-downs...

SMIC

Taiwan Semiconductor

SoftBank

SoftBank Group Corp.

Cheche

Mobileye Global

Ategrity Specialty Holdings LLC

Lakeland Industries

Direxion Semicon Bear 3X

Direxion Semicon Bull 3X

iShares Semiconductor ETF

Semiconductor

SMIC HK SDR 5to1

Cheche Group - CW28

INTEL-T

Intel (Minutes): 18A is expected to contribute to profits by the end of 2026

CICC Downgrades Profami's 2026 Adjusted Net Profit Forecast

SISRAM MED released FY2025 Q3 earnings on March 23, 2026 (BJT) with actual revenue of HKD 777.77 M and EPS of HKD 0.1046

SISRAM MED released FY2025 9 Months Earnings on March 23, 2026 (BJT) with actual revenue of HKD 2.071 B and EPS of HKD 0.2116

Rejuveron Medical Technology Reports 4.7% Revenue Growth and 24.32% Drop in Shareholders' Profit for FY2025

SISRAM MED released FY2025 Q4 earnings on March 23 After-Market (BJT), actual revenue HKD 777.48 M, actual EPS HKD 0.1045

SISRAM MED released FY2025 Annual Earnings on March 23 After-Market (BJT), actual revenue HKD 2.849 B (forecast HKD 3.069 B), actual EPS HKD 0.3165 (forecast HKD 0.5445)

SISRAM MED to release FY2025 earnings on March 23 After-Market (BJT), forecast revenue HKD 3.083 B, EPS HKD 0.5472

Revalgo Medical Tech Signs Cooperation Intent with Xingmatek Medical Tech for Localization

Refoo Medical's DAXXIFY Passes Quality Standard Inspection by China Institute for Pharmaceutical and Biological Products

SISRAM MED released FY2025 Q1 earnings on August 20 (BJT), actual revenue HKD 643.65 M, actual EPS HKD 0.0532

ReAve Medical Technology's Revenue Down 1.9% in H1 2025 Earnings Report

SISRAM MED released FY2025 Semi-Annual earnings on August 20 After-Market (BJT), actual revenue HKD 1.293 B, actual EPS HKD 0.107

SISRAM MED released FY2025 Q2 earnings on August 20 After-Market (BJT), actual revenue HKD 649.49 M, actual EPS HKD 0.0537

SISRAM MED to Release FY2025 Semi-Annual Earnings on August 20, 2025 (BJT)

Revalo Medical Technology Launches AI-based Skincare Product

Revaldo Medical Technology Strengthens Market Penetration in Asia-Pacific and North America

SISRAM MED released FY2024 9 Months Earnings on March 19 (BJT), with actual revenue of 2.02 B HKD and EPS of 0.3001 HKD

SISRAM MED released FY2024 Q3 earnings on March 19 (BJT), actual revenue 700.9 M HKD, actual EPS 0.1173 HKD

Furu Medical Technology Announces 2024 Annual Results, Revenue of $349 Million, Down 2.83% Year-on-Year

Furuya Medical Technology Announces Final Dividend of HKD 0.126 per Share for Fiscal Year 2024

CENTRAL DEV H

FAMEGLOW

ZHONGSHENJIANYE

TJCD

NEW GONOW RV

REALWAY CAPITAL

ZXZN QI-HOUSE

51WORLD

CH CITY INFRA

EASYHOLD GROUP

600196

159506

520690

159849

513700

562600

159883

516500

512290

Sisram Medical Ltd. has signed a non-binding memorandum of understanding with Sinmait Medical Technology to explore local manufacturing of its energy-based medical devices in China. This partnership aims to shorten supply chains and enhance local responsiveness, positioning China as a regional production hub. The arrangements may be subject to Hong Kong listing rules and further regulatory announcements. The current analyst rating for Sisram Medical stock (HK:1696) is a Hold with a price target of HK$4.50.

Tip Ranks

FOSUN PHARMA

Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF

Bosera Hang Seng SCHK Innovative Drug Select ETF

China Merchants CSI Biotechnology Theme ETF

Penghua CSI HK Connect Health Care Composite ETF

ChinaAMC CSI All Share Health Care Devices ETF

Maxwealth CSI All Share Medical Apparatus and Instruments ETF

ChinaAMC CSI Biotechnology Theme ETF

Guotai CSI Bio-medicine ETF

Sisram Medical Explores Local Manufacturing Partnership in China with Fosun Unit

SISRAM MED announced changes in senior management positions: Liu Yi has been reassigned to non-executive director and has resigned as chairman; Lior Moshe DAYAN has been appointed as executive director and chairman, no longer serving as CEO; Ben David has been appointed as CEO, and Li Jiahong has been appointed as co-CEO. Ben David joined the group in 2009 and previously served as executive vice president of global sales, responsible for global sales and marketing strategy

AASTOCKS

Changes in the positions of senior personnel at SISRAM MED

SISRAM MED(01696.HK)

Sisram Medical Explores Local Manufacturing Partnership in China with Fosun Unit

Changes in the positions of senior personnel at SISRAM MED

Global Tech Blitz: Nvidia Invests in Synopsys, Apple AI Shakeup, Alibaba Updates AI Model | Today's Important News Recap